Found: 4
Select item for more details and to access through your institution.
AMPK β1 reduces tumor progression and improves survival in p53 null mice.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 9, p. 1143, doi. 10.1002/1878-0261.12079
- By:
- Publication type:
- Article
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 10, p. 1600, doi. 10.1038/mt.2015.119
- By:
- Publication type:
- Article
Combined mTOR Inhibition and OX40 Agonism Enhances CD8<sup>+</sup> T Cell Memory and Protective Immunity Produced by Recombinant Adenovirus Vaccines.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 4, p. 860, doi. 10.1038/mt.2011.281
- By:
- Publication type:
- Article
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05395-y
- By:
- Publication type:
- Article